KODKodiak Sciences Inc.
$87.64+487% 1Y
$87.64
$14.1052 weeks$99.91
KOD as reported
- Net income
- −$242M
Net income · +21% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$160M
Free cash flow · +38% year on year · trailing twelve months to Q2 2026
- EPS
- −$4.19
EPS · +10% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$242M | +21% | Q2 2026 |
| EPS | −$4.19 | +10% | Q2 2026 |
| ROE | −416% | n/a | Q2 2026 |
| ROA | −84% | n/a | Q2 2026 |
| Free cash flow | −$160M | +38% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Kodiak Sciences Inc. (KOD) · Net incomeNet incomeKodiak Sciences Inc. (KOD)
On our screens:Most shorted stocks